Company Name:Gilead Sciences, Inc.
CEO: Daniel P. O'Day

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.


Key numbers

Market Capitalization:91581553700
Shares Outstanding: 1254370000
Float: 1249723814
Next Earning Date:2020-07-30
TTm EPS: 3.9194
TTm Dividend Rate: 2.57
200 days moving average:71.18
50 days moving average: 75.39
One day percent Change: 3.16



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,